Annual report
7915.TEDINET S100T30E
Period2023-01-01 → 2023-12-31
Filed2024-03-22
StandardIFRS
ConsolidatedYes
Data checks19 of 19 passed
Key figures · 164
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥167.7bn | 2023-01-01 → 2023-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥194.0bn | 2022-01-01 → 2022-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥189.3bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales IFRS (5-year summary) |
| Revenue | ¥180.0bn | 2020-01-01 → 2020-12-31d | Cons. | Net sales IFRS (5-year summary) |
| Revenue | ¥173.2bn | 2019-01-01 → 2019-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥174.0bn | 2019-01-01 → 2019-12-31d | Cons. | Net sales IFRS (5-year summary) |
| Operating income | −¥3.8bn | 2023-01-01 → 2023-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥9.5bn | 2022-01-01 → 2022-12-31 | Cons. | Operating profit loss IFRS |
| Ordinary income | −¥4.7bn | 2019-01-01 → 2019-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥2.8bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥12.4bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥19.5bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥7.0bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | −¥16.6bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | −¥3.0bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥10.1bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥15.9bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥7.1bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | −¥4.1bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥17.2bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | −¥3.0bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥10.1bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss IFRS |
| Total assets | ¥217.9bn | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥230.2bn | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥209.3bn | at 2021-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥199.6bn | at 2020-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥190.6bn | at 2019-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥186.8bn | at 2019-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥107.0bn | at 2023-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥118.7bn | at 2022-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥110.9bn | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥111.5bn | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥98.3bn | at 2021-12-31d | Cons. | Equity IFRS |
| Net assets / equity | ¥86.3bn | at 2019-12-31d | Cons. | Net assets (5-year summary) |
| Equity (owners) | ¥110.9bn | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥111.6bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥98.3bn | at 2021-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥81.9bn | at 2020-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥75.0bn | at 2019-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥37.9bn | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥54.3bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥42.3bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥25.1bn | at 2020-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥17.5bn | at 2019-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.5bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥12.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥18.8bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥14.6bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥164m | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.6bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥8.0bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥4.4bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥6.9bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥1.4bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥4.9bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.9bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥12.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥1.1bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥2.6bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥6.0bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥5.1bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.7bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥-61.13 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥203.65 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥318.35 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥141.34 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥-82.77 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-344.27 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥317.16 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥137.78 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥-344.27 | 2019-01-01 → 2019-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥2,281.64 | at 2023-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥2,257.47 | at 2022-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,972.89 | at 2021-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,638.46 | at 2020-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,728.26 | at 2019-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,502.74 | at 2019-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 50.9% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 48.5% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 47.0% | at 2021-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 41.1% | at 2020-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 45.3% | at 2019-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.2% | at 2019-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | -2.7% | 2023-01-01 → 2023-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 9.7% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 17.6% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 9.0% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | -4.7% | 2019-01-01 → 2019-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | -20.6% | 2019-01-01 → 2019-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 5,221 | at 2023-12-31 | Cons. | Number of employees |
| Employees | 5,325 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 5,409 | at 2021-12-31d | Cons. | Number of employees |
| Employees | 5,390 | at 2020-12-31d | Cons. | Number of employees |
| Employees | 5,718 | at 2019-12-31d | Cons. | Number of employees |
| Revenue | ¥68.9bn | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥93.5bn | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥113.0bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥115.7bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥108.2bn | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥3.4bn | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Operating income | ¥1.5bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Ordinary income | ¥1.8bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥9.9bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥6.9bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥437m | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥4.9bn | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥11.9bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Net income | −¥4.5bn | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | ¥10.8bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | ¥6.2bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥5.5bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥1.3bn | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥142.9bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥159.2bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥150.3bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥154.0bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥150.0bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥58.8bn | at 2023-12-31 | Standalone | Liabilities |
| Total liabilities | ¥68.4bn | at 2022-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥84.1bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥90.7bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥85.3bn | at 2021-12-31d | Standalone | Net assets |
| Net assets / equity | ¥81.5bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥79.2bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥15.2bn | at 2023-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥43.0bn | at 2022-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-91.35 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥217.18 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥124.85 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥110.97 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-25.23 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥124.38 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥108.17 | 2020-01-01 → 2020-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥50 | 2023-01-01 → 2023-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2022-01-01 → 2022-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥35 | 2019-01-01 → 2019-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,729.67 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,836.15 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,711.67 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,629.17 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,587.25 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 58.8% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.0% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.7% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.9% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.8% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | -5.1% | 2023-01-01 → 2023-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.3% | 2022-01-01 → 2022-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.5% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | -1.6% | 2019-01-01 → 2019-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 50,855,000 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 50,855,000 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 50,855,000 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 50,855,000 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 50,855,000 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 720 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 710 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 731 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 720 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 819 | at 2019-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-12-31 | ¥9.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2023-12-31 | ¥10.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-12-31 | −¥860m |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-12-31 | −¥1.2bn |
| Reconciling Itemsreconciling | segment assets | at 2023-12-31 | ¥67.8bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-12-31 | −¥3.0bn |
| Devicesreportable segment | employees | at 2023-12-31 | 912 pure |
| Devicesreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥54.9bn |
| Devicesreportable segment | segment assets | at 2023-12-31 | ¥34.4bn |
| Devicesreportable segment | segment profit | 2023-01-01 → 2023-12-31 | −¥1.6bn |
| Industrial Materialsreportable segment | employees | at 2023-12-31 | 2461 pure |
| Industrial Materialsreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥69.0bn |
| Industrial Materialsreportable segment | segment assets | at 2023-12-31 | ¥54.7bn |
| Industrial Materialsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥93m |
| Medical Technologiesreportable segment | employees | at 2023-12-31 | 1263 pure |
| Medical Technologiesreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥36.0bn |
| Medical Technologiesreportable segment | segment assets | at 2023-12-31 | ¥50.3bn |
| Medical Technologiesreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥1.5bn |
| Other And Corporate R And D Administrativereportable segment | employees | at 2023-12-31 | 585 pure |
| —segment total | revenue | 2023-01-01 → 2023-12-31 | ¥159.8bn |
| —segment total | segment assets | at 2023-12-31 | ¥139.4bn |
| —segment total | segment profit | 2023-01-01 → 2023-12-31 | ¥6m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-12-31 | ¥168.9bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-12-31 | ¥150.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-12-31 | −¥853m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-12-31 | ¥9.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-12-31 | ¥10.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-12-31 | −¥759m |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-12-31 | −¥1.3bn |
| Reconciling Itemsreconciling | segment assets | at 2022-12-31 | ¥80.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | −¥1.9bn |
| Devicesreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥80.0bn |
| Devicesreportable segment | segment assets | at 2022-12-31 | ¥35.9bn |
| Devicesreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥8.3bn |
| Industrial Materialsreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥73.8bn |
| Industrial Materialsreportable segment | segment assets | at 2022-12-31 | ¥56.8bn |
| Industrial Materialsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥3.4bn |
| Medical Technologiesreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥32.5bn |
| Medical Technologiesreportable segment | segment assets | at 2022-12-31 | ¥47.2bn |
| Medical Technologiesreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥490m |
| —segment total | revenue | 2022-01-01 → 2022-12-31 | ¥186.2bn |
| —segment total | segment assets | at 2022-12-31 | ¥139.8bn |
| —segment total | segment profit | 2022-01-01 → 2022-12-31 | ¥12.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-01-01 → 2022-12-31 | ¥195.3bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-12-31 | ¥150.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-01-01 → 2022-12-31 | ¥11.4bn |
| Devicesreportable segment | employees | at 2023-12-31 | 198 pure |
| Industrial Materialsreportable segment | employees | at 2023-12-31 | 199 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,075
| Item | Context | Value | Unit |
|---|---|---|---|
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2023-01-01 | |
| Current period end date | FilingDateInstant | 2023-12-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2023-12-31 | |
| Previous fiscal year start date | FilingDateInstant | 2022-01-01 | |
| Comparative period end date | FilingDateInstant | 2022-12-31 | |
| Previous fiscal year end date | FilingDateInstant | 2022-12-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Disclosure of sustainability related financial information (text) | FilingDateInstant | Text · Plus | |
| Governance (text) | FilingDateInstant | Text · Plus | |
| Risk management (text) | FilingDateInstant | Text · Plus | |
| Strategy climate change (text) | FilingDateInstant | Text · Plus | |
| Metrics and targets climate change (text) | FilingDateInstant | Text · Plus | |
| Strategy human capital (text) | FilingDateInstant | Text · Plus | |
| Policy on human resource development and improvement of internal environment strategy human capital (text) | FilingDateInstant | Text · Plus | |
| Metrics and targets human capital (text) | FilingDateInstant | Text · Plus | |
| Description of metrics related to policy on human resource development and improvement of internal environment and targets and results using such metrics metrics and targets human capital (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Research and development activities (text) | FilingDateInstant | Text · Plus | |
| Overview of capital expenditures etc (text) | FilingDateInstant | Text · Plus | |
| Major facilities (text) | FilingDateInstant | Text · Plus | |
| Planned additions retirements etc of facilities (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所(プライム市場) | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式単元株式数 100株 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Description of rights plan (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Shareholding by shareholder category (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 19 of 19 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |